ArticleEClinicalMedicine2025

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study.

Junning Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.